NEW YORK (AP) — The substance that caused Manny Ramirez to test positive for a banned substance last year was testosterone, a person familiar with the situation told The Associated Press.
The administrator of baseball's drug program issued his annual report on Friday. The document lists the substances that resulted in seven positive tests for performance-enhancing drugs that led to discipline.
Six players were suspended earlier this year for taking prohibited substances and, in each case, the substance that triggered the positive test was announced under a change to baseball's drug agreement.
However, one positive test was unaccounted for and it came from Ramirez, the person said, speaking on condition of anonymity because that detail wasn't included in the report.
Ramirez, then playing for Tampa Bay, at first retired in April 2011 rather than face a 100-game suspension for his second failed drug test. He changed his mind last December — after the Independent Program Administrator's 2011 report — and an agreement was reached that suspended him for 50 games rather than 100 because he sat out nearly all of the 2011 season. The failed testosterone test was then included in the 2012 figures.
After signing a minor league contract with Oakland this year, Ramirez asked to be released in mid-June without reaching the majors.
Ramirez, 14th on the career list with 555 home runs, was suspended for 50 games in 2009 while playing with the Los Angeles Dodgers. While the substance causing that suspension was not announced, at the time a person familiar with the details said Ramirez used the female fertility drug HCG, or human chorionic gonadotropin. The substance stimulates natural testosterone production, which shuts down during a cycle of steroids use.
Melky Cabrera, Bartolo Colon and Yasmani Grandal also tested positive for testosterone in 2012. The other PED positives came up in tests from Guillermo Mota (Clenbuterol), Marlon Byrd (Tamoxifen) and Freddy Galvis (Clostebol). All were given 50-game suspensions.
Find out what’s latest in business,finance & entertainment